Osteogenesis Imperfecta Genotypes and Genotype-Phenotype Relationships - Osteogenesis Imperfecta - page 100

[15] van Dijk FS, Huizer M, Kariminejad A, et al. Complete COL1A1

allele deletions in osteogenesis imperfecta. Genet Med 2010;
12:736-41.

[33] Ries-Levavi L, Ish-Shalom T, Frydman M, et al. Genetic and bio-

chemical analyses of Israeli osteogenesis imperfecta patients.
Hum Mutat 2004 Mutation in Brief #701 Online.

[16] Pollitt R, McMahon R, Nunn J, et al. Mutation analysis of

COL1A1 and COL1A2 in patients diagnosed with osteogenesis
imperfecta type I-IV. Hum Mutat 2006;27:716.

[34] Xu Z, Li Y, Zhang X, et al. Identiication and molecular character-

ization of two novel mutations in COL1A2 in two Chinese families
with osteogenesis imperfecta. J Genet Genomics 2011;38:149-56.

[17] Chu ML, Gargiulo V, Williams CJ, Ramirez F. Multiexon dele-

tion in an osteogenesis imperfecta variant with increased type
III collagen mRNA. J Biol Chem 1985;260:691-4.

[35] Wolf A, Caliebe A, Thomas NST, et al. Single base-pair substitu-

tions at the translation initiation sites of human genes as a cause
of inherited disease. Hum Mutat 2011;32:1137-43.

[18] Bodian DL, Chan TF, Poon A, et al. Mutation and polymorphism

spectrum in osteogenesis imperfecta type II: implications for gen-
otype-phenotype relationships. Hum Mol Genet 2009;18:463-71.

[36] Reis FC, Alexandrino F, Steiner CE, Norato DY, Cavalcanti DP,

Sartorato EL. Molecular indings in Brazilian patients with
osteogenesis imperfecta. J Appl Genet 2005;46:105-8.

[19] Mundlos S, Chan D, Weng YM, Sillence DO, Cole WG, Bateman JF.

Multiexon deletions in the type I collagen COL1A2 gene in osteo-
genesis imperfecta. Molecules containing the shortened α2(I) chains
show differential incorporation into the bone and extracellular
matrix. J Biol Chem 1996;271:21068-74.

[37] Nadyrshina DD, Khusainova RI, Khusnutdinova EK. Studies of

type I collagen ( COL1A1 ) α1 chain in patients with osteogenesis
imperfecta. Russ J Genet 2012;48:321-8.

[38] Swinnen FKR, De Leenheer EMR, Coucke PJ, Cremers CWRJ,

Dhooge IJM. Audiometric, surgical, and genetic indings in 15
ears of patients with osteogenesis imperfecta. Laryngoscope 2009;
119:1171-9.

[20] Willing MC, Cohn DH, Starman B, Holbrook KA, Greenberg CR,

Byers PH. Heterozygosity for a large deletion in the α2(I) collagen
gene has a dramatic effect on type I collagen secretion and pro-
duces perinatal lethal osteogenesis imperfecta. J Biol Chem 1988;
263:8398-404.

[39] Schwarze U, Hata R-I, McKusick VA, et al. Rare autosomal reces-

sive cardiac valvular form of Ehlers-Danlos syndrome results
from mutations in the COL1A2 gene that activate the nonsense-
mediated RNA decay pathway. Am J Hum Genet 2004;74:917-30. [21] Marini JC, Forlino A, Cabral WA, et al. Consortium for osteogen-

esis imperfecta mutations database of glycine substitutions and
exon skipping defects: lethal regions in the helical portion of type I
collagen chains align with collagen binding sites for integrin and
proteoglycans. Hum Mutat 2007;28:209-21.

[40] Takagi M, Hori N, Chinen Y, et al. Heterozygous C-propeptide

mutations in COL1A1: osteogenesis imperfecta type IIC and
dense bone variant. Am J Med Genet A 2011;155A:2269-73.

[41] Bateman JF, Lamande SR, Dahl HH, Chan D, Mascara T, Cole

WG. A frameshift mutation results in a truncated nonfunctional
carboxyl-terminal pro alpha 1(I) propeptide of type I collagen in
osteogenesis imperfecta. J Biol Chem 1989;264:10960-64.

[22] Cabral WA, Makareeva E, Colige A, et al. Mutations near amino

end of α1(I) collagen cause combined OI / EDS by interference with
N-propeptide processing. J Biol Chem 2005;280:19259-69.

[23] Marini JC, Grange DK, Gottesman GS, Lewis MB, Koeplin DA.

Osteogenesis imperfecta type IV. Detection of a point mutation in
one α1(I) collagen allele (COL1A1) by RNA / RNA hybrid analysis.
J Biol Chem 1989;264:11893-900.

[42] Cartegni L, Chew SL, Krainer AR. Listening to silence and

understanding nonsense: exonic mutations that affect splicing.
Nat Rev Genet 2002;3:285-98.

[43] Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR. ESEinder:

a web resource to identify exonic splicing enhancers. Nucleic
Acids Res 2003;31:3568-71.

[24] Byers PH, Wallis GA. Willing MC. Osteogenesis imperfecta:

translation of mutation to phenotype. J Med Genet 1991;28:
433-42. [44] Smith PJ, Zhang C, Wang J, Chew SL, Zhang MQ, Krainer AR.

An increased speciicity score matrix for the prediction of
SF2 / ASF-speciic exonic splicing enhancers. Hum Mol Genet
2006;15:2490-508.

[25] Wang Q, Orrison BM, Marini JC. Two additional cases of osteo-

genesis imperfecta with substitutions for glycine in the α2(I) col-
lagen chain. A regional model relating mutation location with
phenotype. J Biol Chem 1993;268:25162-67. [45] Huang HY, Chien CH, Jen KH, Huang HD. RegRNA: an inte-

grated web server for identifying regulatory RNA motifs and
elements. Nucleic Acids Res 2006;34:W429-34.

[26] Di Lullo GA, Sweeney SM, Körkkö J, Ala-Kokko L, San Antonio

JD. Mapping the ligand-binding sites and disease-associated
mutations on the most abundant protein in the human, type I
collagen. J Biol Chem 2002;277:4223-31.

[46] Miskulin M, Dalgleish R, Kluve-Beckerman B, et al. Human type

III collagen gene expression is coordinately modulated with the
type I collagen genes during ibroblast growth. Biochemistry
1986;25:1408-13.

[27] Rosenberg K, Olsson H, Mörgelin M, Heinegård D. Cartilage

oligomeric matrix protein shows high afinity zinc-dependent
interaction with triple helical collagen. J Biol Chem 1998;273:
20397-403.

[47] Baralle D, Baralle M. Splicing in action: assessing disease caus-

ing sequence changes. J Med Genet 2005;42:737-48.

[28] Keene DR, San Antonio JD, Mayne R, et al. Decorin binds

near the C terminus of type I collagen. J Biol Chem 2000;275:
21801-04.

[48] Nicholls AC, Oliver J, Renouf DV, Heath DA, Pope FM. The

molecular defect in a family with mild atypical osteogenesis
imperfecta and extreme joint hypermobility: exon skipping
caused by an 11-bp deletion from an intron in one COL1A2 alelle.
Hum Genet 1992;88:627-33.

[29] Hartikka H, Kuurila K, Körkkö J, et al. Lack of correlation between

the type of COL1A1 or COL1A2 mutation and hearing loss in
osteogenesis imperfecta patients. Hum Mutat 2004;24:147-54. [49] Feshchenko S, Brinckmann J, Lehmann HW, Koch HG, Müller

PK, Kügler S. Identiication of a new heterozygous point muta-
tion in the COL1A2 gene leading to skipping of exon 9 in a
patient with joint laxity, hyperextensibility of skin and blue
sclerae. Hum Mutat 1998;12:138.

[30] Pyott SM, Pepin MG, Schwarze U, Yang K, Smith G, Byers PH.

Recurrence of perinatal lethal osteogenesis imperfecta in sib-
ships: parsing the risk between parental mosaicism for dominant
mutations and autosomal recessive inheritance. Genet Med 2011;
13:125-30. [50] Kuivaniemi H, Sabol C, Tromp G, Sippola-Thiele M, Prockop DJ.

A 19 base pair deletion in the pro-α2(I) gene of type I procollagen
that causes in-frame RNA splicing from exon 10 to exon 12 in a
proband with atypical osteogenesis imperfecta and his asymp-
tomatic mother. J Biol Chem 1988;263:11407-13.

[31] Venturi G, Tedeschi E, Mottes M, et al. Osteogenesis imperfecta:

clinical, biochemical and molecular indings. Clin Genet 2006;
70:131-9.

[32] Lindahl K, Barnes AM, Fratzl-Zelman N, et al. COL1 C-propeptide

cleavage site mutations cause high bone mass osteogenesis imper-
fecta. Hum Mutat 2011;32:598-609.

[51] Desmet FO, Hamroun D, Lalande M, Collod-Béroud G,

Claustres M, Béroud C. Human splicing inder: an online